Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine hydrochloride injection vs dexmedetomidine hydrochloride in sodium chloride for procedural sedation in non-intubated patients
CTR20190905Phase 3Completed
- Sponsor
- Chengdu Brilliant Pharmaceutical Co., Ltd.
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in procedural sedation and analgesia (PSA), sponsored by Chengdu Brilliant Pharmaceutical Co., Ltd.. Started May 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on CTR20190905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190905.